000 01291 a2200361 4500
005 20250515123943.0
264 0 _c20090728
008 200907s 0 0 eng d
022 _a0269-8811
024 7 _a10.1177/0269881108091257
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aChandran, M
245 0 0 _aCatatonia, neuroleptics and brain damage--a case report.
_h[electronic resource]
260 _bJournal of psychopharmacology (Oxford, England)
_cMar 2009
300 _a223-6 p.
_bdigital
500 _aPublication Type: Case Reports; Journal Article
650 0 4 _aAmisulpride
650 0 4 _aAntipsychotic Agents
_xadverse effects
650 0 4 _aAtrophy
650 0 4 _aCatatonia
_xchemically induced
650 0 4 _aEpilepsy, Temporal Lobe
_xcomplications
650 0 4 _aFemale
650 0 4 _aFrontal Lobe
_xpathology
650 0 4 _aHumans
650 0 4 _aMiddle Aged
650 0 4 _aNeuroleptic Malignant Syndrome
_xdiagnosis
650 0 4 _aParietal Lobe
_xpathology
650 0 4 _aPsychotic Disorders
_xdrug therapy
650 0 4 _aSulpiride
_xadverse effects
700 1 _aEl-Shazly, M
773 0 _tJournal of psychopharmacology (Oxford, England)
_gvol. 23
_gno. 2
_gp. 223-6
856 4 0 _uhttps://doi.org/10.1177/0269881108091257
_zAvailable from publisher's website
999 _c18047098
_d18047098